181 related articles for article (PubMed ID: 9334805)
1. Photodynamic therapy using mTHPC for malignant disease in the oral cavity.
Fan KF; Hopper C; Speight PM; Buonaccorsi GA; Bown SG
Int J Cancer; 1997 Sep; 73(1):25-32. PubMed ID: 9334805
[TBL] [Abstract][Full Text] [Related]
2. mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma.
Hopper C; Kübler A; Lewis H; Tan IB; Putnam G
Int J Cancer; 2004 Aug; 111(1):138-46. PubMed ID: 15185355
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements.
Glanzmann T; Forrer M; Blant SA; Woodtli A; Grosjean P; Braichotte D; van den Bergh H; Monnier P; Wagnières G
J Photochem Photobiol B; 2000 Aug; 57(1):22-32. PubMed ID: 11100834
[TBL] [Abstract][Full Text] [Related]
4. Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck.
Copper MP; Tan IB; Oppelaar H; Ruevekamp MC; Stewart FA
Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):709-11. PubMed ID: 12874068
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy using meta-tetrahydroxyphenylchlorin (Foscan) for the treatment of vulval intraepithelial neoplasia.
Campbell SM; Gould DJ; Salter L; Clifford T; Curnow A
Br J Dermatol; 2004 Nov; 151(5):1076-80. PubMed ID: 15541088
[TBL] [Abstract][Full Text] [Related]
6. mTHPC mediated, systemic photodynamic therapy (PDT) for nonmelanoma skin cancers: Case and literature review.
Horlings RK; Terra JB; Witjes MJ
Lasers Surg Med; 2015 Dec; 47(10):779-87. PubMed ID: 26462858
[TBL] [Abstract][Full Text] [Related]
7. Experimental assessment of photodynamic therapy with chlorins for malignant mesothelioma.
Ris HB; Giger A; Hof VI; Mettler D; Stewart JC; Althaus U; Altermatt HJ
Eur J Cardiothorac Surg; 1997 Oct; 12(4):542-8. PubMed ID: 9370396
[TBL] [Abstract][Full Text] [Related]
8. Localization of liposomal mTHPC formulations within normal epithelium, dysplastic tissue, and carcinoma of oral epithelium in the 4NQO-carcinogenesis rat model.
de Visscher SA; Witjes MJ; van der Vegt B; de Bruijn HS; van der Ploeg-van den Heuvel A; Amelink A; Sterenborg HJ; Roodenburg JL; Robinson DJ
Lasers Surg Med; 2013 Dec; 45(10):668-78. PubMed ID: 24174342
[TBL] [Abstract][Full Text] [Related]
9. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT
Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
[TBL] [Abstract][Full Text] [Related]
10. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy for gastrointestinal tumors using three photosensitizers--ALA induced PPIX, Photofrin and MTHPC. A pilot study.
Mĺkvy P; Messmann H; Regula J; Conio M; Pauer M; Millson CE; MacRobert AJ; Bown SG
Neoplasma; 1998; 45(3):157-61. PubMed ID: 9717528
[TBL] [Abstract][Full Text] [Related]
12. Foscan and foslip based photodynamic therapy in osteosarcoma in vitro and in intratibial mouse models.
Meier D; Botter SM; Campanile C; Robl B; Gräfe S; Pellegrini G; Born W; Fuchs B
Int J Cancer; 2017 Apr; 140(7):1680-1692. PubMed ID: 27943293
[TBL] [Abstract][Full Text] [Related]
13. A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia.
Gossner L; May A; Sroka R; Ell C
Endoscopy; 1999 Jun; 31(5):370-6. PubMed ID: 10433046
[TBL] [Abstract][Full Text] [Related]
14. mTHPC-mediated photodynamic therapy of early stage oral squamous cell carcinoma: a comparison to surgical treatment.
de Visscher SA; Melchers LJ; Dijkstra PU; Karakullukcu B; Tan IB; Hopper C; Roodenburg JL; Witjes MJ
Ann Surg Oncol; 2013 Sep; 20(9):3076-82. PubMed ID: 23686100
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy outcome for oral dysplasia.
Jerjes W; Upile T; Hamdoon Z; Mosse CA; Akram S; Hopper C
Lasers Surg Med; 2011 Mar; 43(3):192-9. PubMed ID: 21412802
[TBL] [Abstract][Full Text] [Related]
16. Optimization of treatment parameters for Foscan-PDT of basal cell carcinomas.
Betz CS; Rauschning W; Stranadko EP; Riabov MV; Albrecht V; Nifantiev NE; Hopper C
Lasers Surg Med; 2008 Jul; 40(5):300-11. PubMed ID: 18563776
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic dose does not correlate with long-term tumor response to mTHPC-PDT performed at several drug-light intervals.
Wang KK; Mitra S; Foster TH
Med Phys; 2008 Aug; 35(8):3518-26. PubMed ID: 18777912
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy of a transplanted pancreatic cancer model using meta-tetrahydroxyphenylchlorin (mTHPC).
Mikvy P; Messman H; MacRobert AJ; Pauer M; Sams VR; Davies CL; Stewart JC; Bown SG
Br J Cancer; 1997; 76(6):713-8. PubMed ID: 9310235
[TBL] [Abstract][Full Text] [Related]
19. [Squamous cell carcinoma of the head and neck. Photodynamic therapy with Foscan].
Lorenz KJ; Maier H
HNO; 2008 Apr; 56(4):402-9. PubMed ID: 17516041
[TBL] [Abstract][Full Text] [Related]
20. Non-metastatic cutaneous squamous cell carcinoma treated with photodynamic therapy using intravenous mTHPC.
Jerjes W; Yousif AA; Hamdoon Z; Hopper C
Photodiagnosis Photodyn Ther; 2019 Dec; 28():172-176. PubMed ID: 31394299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
